NICE recommends osimertinib for advanced EGFR-positive NSCLC

PDF / 167,033 Bytes
1 Pages / 595.245 x 841.846 pts (A4) Page_size
54 Downloads / 223 Views

1173-5503/20/0863-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 3 Oct 2020 No. 863

1

Data Loading...

Recommend Documents

NICE recommends polatuzumab vedotin combination for DLBCL

185 46 163KB

NICE recommends apixiban and ranibizumab . . .

165 13 112KB

NICE recommends caplacizumab for acute acquired TTP

149 71 163KB

NICE recommends isatuximab with pomalidomide and dexamethasone

151 71 163KB

NICE recommends Zio XT for detecting arrhythmias, with a caveat

182 15 163KB

NICE recommends BP monitor for atrial fibrillation detection

151 70 83KB

NICE OKs arthritis therapies, not pemetrexed for NSCLC

138 35 121KB